RISK FACTORS FOR RECURRENCES OF CENTRAL SEROUS CHORIORETINOPATHY

被引:54
作者
Matet, Alexandre [1 ]
Daruich, Alejandra [1 ]
Zola, Marta [1 ]
Behar-Cohen, Francine [1 ,2 ]
机构
[1] Univ Lausanne, Dept Ophthalmol, Jules Gonin Eye Hosp, Fdn Asile des Aveugles, Lausanne, Switzerland
[2] Univ Paris 05, INSERM, U1138,Ctr Rech Cordeliers, Team 17,Physiopathol Ocular Dis Clin Dev,Sorbonne, Paris, France
来源
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES | 2018年 / 38卷 / 07期
基金
瑞士国家科学基金会;
关键词
central serous chorioretinopathy; choroidal thickness; circadian rhythm; fluorescein angiography; natural history; recurrences; retinal pigment epithelium; risk factors; shift work; time factors; SUBFOVEAL CHOROIDAL THICKNESS; TERM FOLLOW-UP; FUNDUS AUTOFLUORESCENCE; SPONTANEOUS RESOLUTION; PHOTODYNAMIC THERAPY; TESTOSTERONE LEVELS; DIURNAL-VARIATION; SERUM CORTISOL; VISUAL-ACUITY; DISTRESS;
D O I
10.1097/IAE.0000000000001729
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose: To describe recurrence patterns and investigate candidate risk factors for recurrences of central serous chorioretinopathy. Methods: In 46 patients with acute central serous chorioretinopathy and follow-up.12 months after first episode resolution, parameters influencing recurrences were retrospectively evaluated using a frailty Cox proportional hazard survival model. Covariates included baseline systemic findings: age, gender, corticosteroid use, stress, shift work, sleep disorder, depression, allergy, cardiovascular risk; baseline optical coherence tomography findings: subfoveal choroidal thickness, pigment epithelial detachment pattern (regular/bump/irregular), number of subretinal hyperreflective foci at leakage site; baseline angiographic findings: fluorescein leakage intensity (intense/moderate/subtle/absent), hyperpermeability pattern on indocyanine-green angiography (focal/multifocal); and episode-related findings: duration and treatment of previous episode. Results: Twenty of 46 subjects (43%) presented >= 1 recurrences during a mean follow-up of 29.9 +/- 9.5 months (range, 15-54 months). Follow-up duration did not differ between cases with or without recurrences (P = 0.3). Worse final visual acuity levels (logarithm of the minimal angle of resolution) were associated with a higher number of episodes during follow-up (P = 0.032, r = 0.28). In a univariate analysis, higher subfoveal choroidal thickness (P = 0.021), nonintense fluorescein leakage (= moderate/subtle/absent, P = 0.033), multiple subretinal hyperreflective foci (P = 0.026), and shift work (P < 0.0001) were significantly associated with recurrences, with a near-significant influence of irregular pigment epithelial detachment (P = 0.093). In a multivariate analysis, higher subfoveal choroidal thickness (P = 0.007), nonintense fluorescein leakage (P = 0.003) and shift work (P < 0.0001) remained significant and independent risk factors for recurrences. Conclusion: Multiple factors influence the risk of central serous chorioretinopathy recurrence. These findings may contribute to identify patients at higher risk, who could benefit from earlier or more intensive treatment.
引用
收藏
页码:1403 / 1414
页数:12
相关论文
共 50 条
  • [21] FAMILIAL CENTRAL SEROUS CHORIORETINOPATHY
    van Dijk, Elon H. C.
    Schellevis, Rosa L.
    Breukink, Myrte B.
    Mohabati, Danial
    Dijkman, Greet
    Keunen, Jan E. E.
    Yzer, Suzanne
    Den Hollander, Anneke I.
    Hoyng, Carel B.
    de Jong, Eiko K.
    Boon, Camiel J. F.
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2019, 39 (02): : 398 - 407
  • [22] Central serous chorioretinopathy: Treatment
    Park, Jong
    Kim, Kiyoung
    Kang, Min
    Kim, Eung
    Yu, Seung-Young
    TAIWAN JOURNAL OF OPHTHALMOLOGY, 2022, 12 (04) : 394 - 408
  • [23] Central serous chorioretinopathy: a review of epidemiology and pathophysiology
    Liew, Gerald
    Quin, Godfrey
    Gillies, Mark
    Fraser-Bell, Samantha
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2013, 41 (02) : 201 - 214
  • [24] Photodynamic therapy for chronic central serous chorioretinopathy
    Ruiz-Moreno, Jose M.
    Lugo, Francisco L.
    Armada, Felix
    Silva, Rufino
    Montero, Javier A.
    Fernando Arevalo, J.
    Arias, Luis
    Gomez-Ulla, Francisco
    ACTA OPHTHALMOLOGICA, 2010, 88 (03) : 371 - 376
  • [25] Therapy options for chronic central serous chorioretinopathy
    Maier, M.
    Valet, V.
    Feucht, N.
    Lohmann, C. P.
    OPHTHALMOLOGE, 2011, 108 (11): : 1027 - 1031
  • [26] Central Serous Chorioretinopathy: Update on Pathophysiology and Treatment
    Nicholson, Benjamin
    Noble, Jason
    Forooghian, Farzin
    Meyerle, Catherine
    SURVEY OF OPHTHALMOLOGY, 2013, 58 (02) : 103 - 126
  • [27] Spectral domain OCT in central serous chorioretinopathy
    Valet, V.
    Lohmann, C. P.
    Maier, M.
    OPHTHALMOLOGE, 2012, 109 (09): : 879 - +
  • [28] Central Serous Chorioretinopathy Treatments: A Mini Review
    Iacono, Pierluigi
    Parodi, Maurizio Battaglia
    Falcomata, Bruno
    Bandello, Francesco
    OPHTHALMIC RESEARCH, 2016, 55 (02) : 76 - 83
  • [29] CILIOCHOROIDAL EFFUSION IN CENTRAL SEROUS CHORIORETINOPATHY
    Terao, Nobuhiro
    Imanaga, Naoya
    Wakugawa, Sorako
    Sawaguchi, Shota
    Tamashiro, Tamaki
    Yamauchi, Yukihide
    Koizumi, Hideki
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2022, 42 (04): : 730 - 737
  • [30] Fundus autofluorescence in acute and chronic central serous chorioretinopathy
    Dinc, Umut Asli
    Tatlipinar, Sinan
    Yenerel, Melda
    Gorgun, Ebru
    Ciftci, Ferda
    CLINICAL AND EXPERIMENTAL OPTOMETRY, 2011, 94 (05) : 452 - 457